Assessing Adherence to Hepatocellular Carcinoma Surveillance Guidelines in Hepatitis B– and Hepatitis C–Infected Patients in Rwanda
JCO Global Oncology · 2026-03 · 12 (3)
DOI: 10.1200/go-25-00357 ↗Kurz gefasst
Leitlinie in der Zeitschrift JCO Global Oncology, 2026-03. Verfasst von Fidel Rubagumya und 12 weiteren Autor:innen. Beteiligte Einrichtung: Rwanda Military Referral and Teaching Hospital, Kigali, Rwanda. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Hepatitis C. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Hepatocellular carcinoma (HCC) is a major cause of cancer mortality in sub-Saharan Africa, with most cases arising from chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite Rwanda's national hepatitis guidelines recommending biannual surveillance with abdominal ultrasound (US) and alpha-fetoprotein (AFP) testing, the extent of adherence remains unknown. This study aimed to assess adherence to HCC surveillance guidelines among HBV- and HCV-infected patients at a national referral hospital in Rwanda. METHODS We conducted a retrospective descriptive study of HBV- and HCV-infected patients attending the Rwanda Military Referral and Teaching Hospital between January 2022 and December 2024. Surveillance adherence was assessed based on the proportion of time covered by abdominal US and AFP testing, with coverage categorized as optimal (100%), intermediate (50%-99%), or poor (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rwanda Military Referral and Teaching Hospital, Kigali, Rwanda.
- School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda.
- Department of Cancer Research, Rwanda Cancer Relief, Kigali, Rwanda.
- Department of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
- Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.
- Division of HIV, STI, Viral Hepatitis and Other Viral Diseases Control, Rwanda Biomedical Center, Kigali, Rwanda.
ORCID-Profile: Fidel Rubagumya, Moses Muwanguzi, Alain Fabrice Mizero, Matthew Jalink, Sulaiman Nanji
Zitieren
APA
Rubagumya, F., Kwizera, V., Havugimana, P., Ramalingam, V., Mutetiwabo, I., Muwanguzi, M., Izabiriza, C., Mizero, A. F., Rwibasira, G. N., Seruyange, E., Narang, T., Jalink, M., & Nanji, S. (2026). Assessing Adherence to Hepatocellular Carcinoma Surveillance Guidelines in Hepatitis B– and Hepatitis C–Infected Patients in Rwanda. JCO Global Oncology, 12(3). https://doi.org/10.1200/go-25-00357
Vancouver
Rubagumya F, Kwizera V, Havugimana P, Ramalingam V, Mutetiwabo I, Muwanguzi M, et al. Assessing Adherence to Hepatocellular Carcinoma Surveillance Guidelines in Hepatitis B– and Hepatitis C–Infected Patients in Rwanda. JCO Global Oncology. 2026;12(3). doi:10.1200/go-25-00357
BibTeX
@article{Rubagumya2026,
author = {Rubagumya, Fidel and Kwizera, Vincent and Havugimana, Phocus and Ramalingam, Vijay and Mutetiwabo, Isabelle and Muwanguzi, Moses and Izabiriza, Christine and Mizero, Alain Fabrice and Rwibasira, Gallican N and Seruyange, Eric and Narang, Tanya and Jalink, Matthew and Nanji, Sulaiman},
title = {Assessing Adherence to Hepatocellular Carcinoma Surveillance Guidelines in Hepatitis B– and Hepatitis C–Infected Patients in Rwanda},
journal = {JCO Global Oncology},
year = {2026},
volume = {12},
number = {3},
doi = {10.1200/go-25-00357}
}
EUVIMED